ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685019 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685019; 2) Community: the network communities that were significantly associated with the response to NSC 685019; 3) Molecule: the relationships between components within communities and NSC 685019; 4) MDR: the compounds that were significantly associated with the NSC 685019.

NSC Compound Enrichment Correlation
NSC 720248 Null 0.0208632511155816 0.46039408
NSC 722316 Null 0.0208632511155816 0.39927193
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0208632511155816 0.19411551
NSC 736200 6-(3-Bromopropyl)-5,6-dihydro3-nitro-5,11-dioxo-9-thiomethyl -11H-indeno[1,2-c]isoquinoline 0.0208632511155816 -0.06310403
NSC 740602 Null 0.0208632511155816 0.43848971
NSC 759216 (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone 0.0208632511155816 -0.24506936
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0208632511155816 0.2315534
NSC 136468 Null 0.0208632511155817 0.40585928
NSC 294979 BLEOMYCIN-BAPP 0.0208632511155817 -0.20775777
NSC 348121 4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- 0.0208632511155817 0.45045115
Total:65  Current:29    [First] [Prev] [Next] [Last]